Cooperative Agreement 2546997
- The National Science Foundation awarded Cooperative Agreement 2545788 to In Virtualis LLC, a SBA-certified women-owned small business, for $1.25 million on August 15, 2026, under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084). The award funds development of an artificial intelligence middleware layer that converts minimal biosignals—such as brain-computer interface and electromyographic inputs—into context-aware, multi-step actions. Current biosignal systems provide...
- This $997,693 Cooperative Agreement awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program aims to develop an interactive health assessment and monitoring platform to improve patient-provider communication and reduce healthcare costs. The project by Literaseed, Inc. integrates electronic health record (EHR) data with natural language processing (NLP) techniques to extract valuable information from medical records, enabling...
- Federal Cooperative Agreement Summary Award Details: Iiam Corporation received a $1.25 million Cooperative Agreement from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), effective July 15, 2025, with completion targeted for June 30, 2027. The project will be performed in San Francisco, California. Products and Services: This Small Business Innovation Research (SBIR) Phase II project delivers a Natural Language Processing (NLP)-driven...
- The National Science Foundation awarded Neuraltrak, Inc. a $1.25 million cooperative agreement on June 15, 2026, under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop AI-powered methods for generating high-quality three-dimensional computed tomography images from limited-angle X-ray data acquired by standard mobile surgical imaging systems. The project addresses a clinical gap: conventional mobile X-ray systems produce primarily two-dimensional images because...
- The National Science Foundation awarded Impulse Wellness LLC $304,997 on July 1, 2026, under the SBIR Fast-Track program to design and validate a wearable electromyography-based stroke rehabilitation system. The recipient will develop a sensor-embedded textile garment integrating reusable electrodes tailored to specific muscles and therapeutic activities, connected to built-in sensors to track muscle electrical activity during dynamic exercises and deliver real-time biofeedback. The system...
- The National Science Foundation awarded Firstthen Inc. a $1,222,567 cooperative agreement on August 1, 2026, to develop an artificial intelligence–enabled mobile coaching platform delivering scalable behavioral support to caregivers. The award funds Phase II of an SBIR project under NSF Technology, Innovation, and Partnerships (CFDA 47.084). The platform embeds validated behavioral strategies into an adaptive mobile application supported by AI-driven coaching. The core technical challenge is...
- The National Science Foundation awarded Zebramd Inc. a $1.239701 million Cooperative Agreement on August 1, 2026, under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop an artificial intelligence-supported clinical decision-making platform for diagnosis and patient management. The platform aggregates multimodal patient data from multiple electronic health record systems through a patient-facing application, deploys backend analytics infrastructure using...
- The National Science Foundation Division of Industrial Innovation awarded Kintsugi Mindful Wellness, Inc. a $1.5 million cooperative agreement under the SBIR PHASE II program titled "AUGMENTING VIRTUAL HEALTHCARE WITH VOICE BIOMARKERS" from May 2021 through April 2025. Under this award, Kintsugi will develop and deliver products and services augmenting virtual healthcare with voice biomarker technology. The NSF Directorate for Engineering seeks to improve quality of life and economic...
- This $276,000 National Science Foundation award through the Technology, Innovation, and Partnerships program will support the development of a cognitive dashboard software platform to aid neurosurgical clinical decision-making. Mindtrace Technologies, Inc. will deliver a turn-key software solution that enables neurosurgical teams to map individual patient brain functions, assess and track measures of mental performance throughout care, and integrate with existing medical imaging and data...
- Neurotechr3 Inc. received a $276,000 STTR Phase I Project Grant award from the National Science Foundation on May 1, 2021 to develop a customized upper extremity telerehabilitation solution. The solution will feature remote therapist interaction and dynamic motor recovery feedback for stroke patients. The award is funded under the NSF Directorate for Engineering's Engineering program (CFDA 47.041) to improve quality of life and economic strength through innovative engineering research and...
The National Science Foundation awarded Smartcharts Inc. a $1.25 million Cooperative Agreement on August 1, 2026, under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop AI-driven visualization technology that transforms unstructured rehabilitation documentation into visual representations of patient functional ability over time. The project builds on Phase I results to refine and validate a rehabilitation-specific data framework representing patient functional progress in speech, occupational, and physical therapy across care settings. Phase II research and development objectives include expanding structured data representations of rehabilitation goals and progress indicators, validating measurement and aggregation methods across larger and varied datasets, and advancing visualization techniques that accurately reflect functional change, stability, and variability. The work employs natural language processing, small language models, ontology-based structures, and expert-in-the-loop validation to extract, structure, and interpret rehabilitation progress data from highly variable clinical documentation. The initial market segment encompasses acute care and inpatient rehabilitation facilities, with planned expansion to outpatient rehabilitation and home health settings. Smartcharts intends to commercialize the technology through a business-to-business software licensing model sold per healthcare facility. Performance occurs in Chicago, Illinois, with a period of performance through July 31, 2028.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.3m | 7/20/26 |